Trieu Vuong - May 2, 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
May 2, 2023
Transactions value $
$4,500
Form type
4
Date filed
5/2/2023, 05:00 PM
Previous filing
Dec 7, 2022
Next filing
May 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $4.5K +100K +0.11% $0.05 90.9M May 2, 2023 Direct
holding OTLC Common Stock 16.8M May 2, 2023 By Autotelic, Inc.
holding OTLC Common Stock 6.87M May 2, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 100,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on May 2, 2023 from the open market at a price of $0.045.